Clinical Trials
All Clinical Trials - Page 18 of 75
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT06901648Phase 2Completed
A Study of HS-20094 in Patients With T2DM
Dulaglutide
- NCT06214741Phase 3Completed
A Study to Test Whether Survodutide (BI 456906) Helps Chinese People Living With Overweight or Obesity to Lose Weight
Survodutide
- NCT06132477Phase 4Recruiting
Impact GLP-1 Agonists Following Bariatric
Semaglutide
- NCT06243536Phase 4Unknown
The Effect of Semaglutide on Disordered Eating Behaviour in Type 2 Diabetic Patients
Semaglutide
- NCT07128394N/ARecruiting
Extra Luteinizing Hormone Improve Embryo Quality in IVF Patients With Low LH During Long GnRH-Agonist Treatment
Gonadorelin
- NCT06264609Phase 4Enrolling By Invitation
Precision Medicine Approach for Osteoporosis - Follow Up Study
Teriparatide
- NCT06154187Phase 3Unknown
Study to Evaluate the Efficacy and Safety of PBK_L2201 in Postmenopausal Women With Osteoporosis
Abaloparatide
- NCT05746039Phase 1/Phase 2Recruiting
Feasibility of Semaglutide in Advanced Lung Disease
Semaglutide
- NCT06171152EARLY_Phase 1Suspended
Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues
Liraglutide
- NCT05896566Phase 2Completed
A Window-of-Opportunity Trial of Giredestrant +/- Triptorelin vs. Anastrozole + Triptorelin in Premenopausal Patients With ER-positive/HER2-negative Early Breast Cancer
Sermorelin
- NCT06699329Phase 1Completed
A Study of Enlicitide Decanoate (MK-0616) and Semaglutide in Healthy Adult Participants (MK-0616-023)
Semaglutide
- NCT06221969Phase 3Completed
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
Tirzepatide
- NCT06176365Phase 3Completed
A Study to Test Whether Survodutide Helps Japanese People Living With Obesity Disease
Survodutide
- NCT05999968Phase 1Terminated
Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial Treatment
Gonadorelin
- NCT05780905Phase 4Recruiting
Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes
Semaglutide
- NCT06192108Phase 3Completed
A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin
Orforglipron
- NCT06056804Phase 2Active Not Recruiting
Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for pMMR/MSS Locally Advanced Mid-low Rectal Cancer
Thymosin-Alpha-1
- NCT05708859Phase 4Recruiting
Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT
Tirzepatide
- NCT06186622Phase 1Completed
A Drug-Drug Interaction Study of Orforglipron (LY3502970) in Healthy Overweight and Obese Participants
Orforglipron
- NCT05659368Phase 2Unknown
Tirzepatide Monotherapy in Patients With Wolfram Syndrome Type 1
Tirzepatide
- NCT07701005N/ACompleted
Non-Invasive Hepatic and Metabolic Index Changes After Incretin Therapy in Overweight/Obesity
Tirzepatide
- NCT07056803N/ACompleted
Oral vs. Subcutaneous Semaglutide in Type 2 Diabetes Mellitus
Semaglutide
- NCT06730958N/ACompleted
Evaluation of Serum Follistatin-Like Protein 1 Levels in Behcet's Disease and Its Association With Disease Activity
Follistatin
- NCT06840847N/ACompleted
Sexual Coercion in Breast Cancer Patients Treated With Luteinizing Hormone-Releasing Hormone Agonists (LHRHa )
Gonadorelin
- NCT06256419N/ARecruiting
Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic Responses to Exenatide in Chinese Patients With T2DM
Exenatide
- NCT06772584N/ACompleted
Ginko Biloba Versus Desmopressin in Treatment of Children With Monosymptomatic Nocturnal Enuresis
Desmopressin
- NCT06164873Phase 3Unknown
A Study of IBI362 9 mg in Chinese Adults With Obesity
Mazdutide
- NCT06401447N/AActive Not Recruiting
TPF Concurrent Chemo-radiotherapy Plus Immunotherapy for Local Advanced Esophageal Squamous Cell Carcinoma
Thymosin-Alpha-1
- NCT05896384Phase 1Completed
A Study in Women With Overweight or Obesity to Test Whether Different Doses of BI 456906 Influence the Amount of a Contraceptive in the Blood
Survodutide
- NCT07304141N/ACompleted
Pharmacological Treatment - An Overview of Its Role in Managing Childhood Obesity
Liraglutide
- NCT06162559Phase 1Recruiting
Neoadjuvant Trastuzumab, Pertuzumab and Tucatinib Without Chemotherapy in HER2-positive Breast Cancer: the TRAIN-4 Study
Gonadorelin
- NCT06282588Phase 2/Phase 3Recruiting
Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers
Gonadorelin
- NCT07057622Phase 3Recruiting
A Phase III Clinical Study to Compare the Safety and Efficacy of 177Lu-DOTATATE Injection and Long-acting Oxytrexine in Adult Patients With NETs
Octreotide
- NCT06148649Phase 2Completed
Phase 2 Study of HEC88473 Injection in Subjects With Type 2 Diabetes Mellitus
Dulaglutide
- NCT06042153Phase 4Active Not Recruiting
DIALYSIS-TIR Study
Semaglutide
- NCT06812559N/ACompleted
Progesterone Primed Ovarian Stimulation Versus GnRH Antagonist Protocols in Women With Polycystic Ovarian Syndrome
Gonadorelin
- NCT05140694Phase 4Unknown
Effect of Empagliflozin and Dulaglutide on MAFLD in Patients With T2D
Dulaglutide
- NCT06046417Phase 2/Phase 3Unknown
A Fully Automated Lyumjev and Pramlintide Delivery System for Adults With Type 1 Diabetes
Pramlintide
- NCT06131437Phase 3Completed
A Research Study to See How Well CagriSema Compared to Tirzepatide Helps People With Obesity Lose Weight
Tirzepatide
- NCT06066528Phase 3Completed
A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight
Survodutide
- NCT06066515Phase 3Completed
A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight
Survodutide
- NCT06164795N/ARecruiting
Sequential Therapies After Osteoanabolic Treatment
Teriparatide
- NCT05851547Phase 2Recruiting
Dose Escalation For INtraprostatic LEsions
Gonadorelin
- NCT05932732Phase 4Completed
Trial Assessing the Impact on Facial Skin Quality, Hydration, and Skin Barrier of Three (3) Hydrafacial Treatments in Adults of All Skin Types.
GHK-Cu
- NCT06077864Phase 3Completed
A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)
Survodutide
- NCT06143956Phase 2Recruiting
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Tirzepatide
- NCT06124807Phase 2Completed
A Study of LY3305677 Compared With Placebo in Adult Participants With Obesity or Overweight
Mazdutide
- NCT06134271Phase 2Unknown
Rezvilutamide Plus Abiraterone for Metastatic Hormone-sensitive Prostate Cancer
Gonadorelin
- NCT05870579Phase 1Active Not Recruiting
[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer
Ghrp-6
- NCT06109311Phase 3Completed
A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 Inhibitor
Orforglipron